Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2006
10/05/2006WO2006059245A3 Compounds for the treatment of cns and amyloid associated diseases
10/05/2006WO2006058012A3 Gonadotropin releasing hormone receptor antagonists
10/05/2006WO2006047196A3 Cgrp receptor antagonists
10/05/2006WO2006026703A3 Chemical compounds
10/05/2006WO2006004684A3 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
10/05/2006WO2005115392A8 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
10/05/2006WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators
10/05/2006US20060223890 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
10/05/2006US20060223885 Derivatives of N-phenyl (piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics
10/05/2006US20060223856 Piperidinyl piperidine derivatives useful as inhibitors of chemokine receptors
10/05/2006US20060223854 For therapy of thromboembolic and/or inflammatory disorders
10/05/2006US20060223849 Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
10/05/2006US20060223831 Bromide and its crystal
10/05/2006US20060223827 Bioreductively activated stilbene prodrugs
10/05/2006US20060223826 Indole derivatives as somatostatin agonists or antagonists
10/05/2006US20060223825 Piperazinyl substituted cyclohexane-1,4-diamines
10/05/2006US20060223823 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/05/2006US20060223822 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/05/2006US20060223821 Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors
10/05/2006US20060223820 Crystalline aripiprazole salts and processes for preparation and purification thereof
10/05/2006US20060223819 Quinoline Derivatives as NK-3 Antagonists
10/05/2006US20060223818 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide methanesulfonate; antiproliferative agent
10/05/2006US20060223817 Crystalline imatinib base and production process therefor
10/05/2006US20060223816 Imatinib mesylate alpha form and production process therefor
10/05/2006US20060223813 2-carboxamide piperazine's such as 4-hexyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridinyl-3-yl-1H-benzoimidazol-5-yl)-amide), are potent follicle stimulating hormone receptor agonists, useful for treatment of infertility in mammals
10/05/2006US20060223804 NK1 antagonists
10/05/2006US20060223802 Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics
10/05/2006US20060223801 Pyrrol derivatives with antibacterial activity
10/05/2006US20060223793 Use of dopamine d3 receptor ligands for the production of drugs for treating renal function disorders
10/05/2006US20060223792 Phenyl and pyridyl LTA4H modulators
10/05/2006US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid
10/05/2006US20060223709 Substituted pyrazolyloxyphenyl derivatives as herbicides
10/05/2006US20060223708 Substituted N-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators
10/05/2006US20060223076 Cyanine dyes and their applications as luminescence quenching compounds
10/05/2006DE102005015957A1 New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders
10/05/2006DE102005014906A1 New pyrimidine compounds e.g. N-((4-ethyl-6((2-(trifluoromethyl) pyridine-4-yl)oxy) pyrimidine-2-yl)methyl) cyclopropane carboxamide useful for combating weeds
10/05/2006CA2603589A1 Inhibitors of histone deacetylase
10/05/2006CA2602510A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists
10/05/2006CA2602351A1 Urea derivative, medicinal composition containing the same, and medicinal use of these
10/05/2006CA2602254A1 Pharmacokinetically improved compounds
10/04/2006EP1707565A1 Losartan potassium crystalline form alpha
10/04/2006EP1707563A2 Methods and compositions utilizing quinazolinones
10/04/2006EP1706402A1 Cathepsin cysteine protease inhibitors
10/04/2006EP1706401A1 Preparation of olmesartan medoxomil
10/04/2006EP1706400A1 Phenyl- 4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl -amine derivatives as igf-ir inhibitors
10/04/2006EP1706388A1 Therapeutic agents ii
10/04/2006EP1706376A1 Imidazole derivatives, processes for preparing them and their uses
10/04/2006EP1706120A1 New derivatives of 6- 4 4 - 1 h - indole-2-sulphonyl)-pipera zin-1-carbonyl-phenyl pyradizin-3-one
10/04/2006EP1706113A1 A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2h-indol-2-one hydrochloride
10/04/2006EP1705990A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
10/04/2006EP1705989A1 Substituted arylpyrazoles as parasiticidal agents
10/04/2006EP1527067B1 4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines
10/04/2006EP1409481B1 Quinoline derivatives and their use as tyrosine kinase inhibitors
10/04/2006EP1406900B1 Novel compounds, their preparation and use
10/04/2006EP1385840B1 Sulfonamides
10/04/2006EP1372653B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists
10/04/2006EP1322621B1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
10/04/2006EP1097382B1 Imidazoline receptor binding compounds
10/04/2006EP0841925B1 Endothelin receptor antagonists
10/04/2006CN1277528C Dyeing composition for kerationous fibres comprising particular dicationic diazo dye
10/03/2006US7115754 Pyrrolidine derivatives as oxytocin antagonists
10/03/2006US7115739 Triazole compounds useful as protein kinase inhibitors
10/03/2006US7115649 Methods of treating skin disorders using thio-oxindole derivatives
10/03/2006US7115646 Cyclic diamines and derivatives as factor Xa inhibitors
10/03/2006US7115645 Central nervous system disorders; antiinflammatory agents
10/03/2006US7115644 Antiinflammatory agents; osteoarthritic; antihistamines; multiple sclerosis; antiulcer agents; skin disorders; graft versus host disease; abtidiabetic agents; Alzheimer's disease; antidiabetic agents
10/03/2006US7115616 Pyrimidinone compounds
10/03/2006US7115607 Substituted piperazinyl amides and methods of use
10/03/2006US7115601 spirocycle-substituted pyrimidinecarboxamides such as N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(1,4,9-triazaspiro[5.5]undec-9-yl)-4-pyrimidinecarboxamide for treating HIV infection and AIDS
10/03/2006US7115600 Histamine-3 receptor modulators
10/03/2006US7115597 Tyrosine kinase inhibitors
10/03/2006CA2474211C Antiproliferative quinazolines
10/03/2006CA2277949C Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions
10/03/2006CA2277018C Use of angiotensin ii antagonists to treat symptomatic heart failure
10/03/2006CA2208611C 4-amino-2-ureidopyrimidine-5-carboxamides, processes for their preparation, pharmaceuticals comprising these compounds, and their use
10/03/2006CA2205906C In-vivo diagnostic process by near infrared radiation
10/03/2006CA2187130C Novel sulphonamides
10/03/2006CA2163169C A process for the production of polyisocyanates at least partially blocked with 3,5-dimethylpyrazole
09/2006
09/28/2006WO2006101977A2 Pyrimidine compounds and methods of use
09/28/2006WO2006101456A1 Bicyclic heterocycles hydroxamate compounds useful as histone deacetylase (hdac) inhibitors
09/28/2006WO2006100588A1 Substituted triazole derivatives as oxytocin antagonists
09/28/2006WO2006100461A1 2-AZETIDINYL-4-(lH-PYRAZOL-3-YLAMINO)PYRIMIDINES AS INHIBITORS OF INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ACTIVITY
09/28/2006WO2006100212A1 Pyrazolyl-pyrimidines as potassium channel modulating agents and their medical use
09/28/2006WO2006100099A1 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents
09/28/2006WO2006100082A2 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof
09/28/2006WO2006100080A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof
09/28/2006WO2006100036A1 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension
09/28/2006WO2006099985A1 Rubber composition comprising an itaconimido-maleimide
09/28/2006WO2006078992A3 Heteroaryl substituted piperazinyl-pyridine analogues
09/28/2006WO2006072608A3 Aryl piperazine derivatives for the treatment of neuropsychiatric disorders
09/28/2006WO2006053342A3 Integrin antagonists useful as anticancer agents
09/28/2006WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds
09/28/2006WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
09/28/2006US20060217562 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
09/28/2006US20060217559 Miticidal triazolidine derivatives
09/28/2006US20060217553 chemical preparation of diketopiperizine derivatives; useful as anticarcinogenic and antifungal agent
09/28/2006US20060217423 Antisecretory agents; antiulcer agents
09/28/2006US20060217420 4-Ring imidazole derivatives as modulators of metabotropic glutamate receptor-5
09/28/2006US20060217418 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity
09/28/2006US20060217416 Antihypoxic agents; adjust concentration of erythropoietin concentration in blood; strokes; antiepileptic agents; neurodegenerative disease ; liver disorders; antiischemic agents